Pulmonary infection in the immuno-compromised patient [[electronic resource] ] : strategies for management / / edited by Carlos Agusti ́and Antoni Torres |
Pubbl/distr/stampa | Chichester, West Sussex, UK ; ; Hoboken, NJ, : John Wiley & Sons, 2009 |
Descrizione fisica | 1 online resource (459 p.) |
Disciplina |
616.2/4
616.24 |
Altri autori (Persone) |
AgustíCarlos
Torres MartíA (Antoni) |
Soggetto topico |
Respiratory infections
Lungs - Infections Immunosuppression - Complications |
Soggetto genere / forma | Electronic books. |
ISBN |
1-282-23742-X
9786612237423 0-470-71417-4 0-470-71418-2 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
PULMONARY INFECTION IN THE IMMUNOCOMPROMISED PATIENT STRATEGIES FOR MANAGEMENT; Contents; Preface; List of Contributors; 1 Lung Immune Defences in the Immunosuppressed Patient; 1.1 Introduction; 1.2 Host defence function in health; 1.3 Host defence function in select immunocompromised patients; 1.4 Summary and future directions for this field; 2 Microbiological Diagnosis of Respiratory Infections in the Immunocompromised; 2.1 Introduction; 2.2 HIV infection and Mycobacterium tuberculosis; 2.3 HIV infection and non tuberculous mycobacteria (NTM); 2.4 HIV and Pneumocystis jirovecii
2.5 Infections in transplant patients or other immunodeficiencies2.6 Concluding remarks; 3 Diagnosis of Pneumonia in Immunocompromised Patient; 3.1 Introduction; 3.2 Clinical assessment; 3.3 Blood cultures; 3.4 Sputum; 3.5 Endotracheal aspirate; 3.6 Non bronchoscopic bronchoalveolar lavage; 3.7 Protected brush sample (PBS); 3.8 Bronchoalveolar lavage (BAL); 3.9 Transbronchial biopsy (TBB); 3.10 Surgical lung biopsy (SLB); 3.11 Sample processing; 3.12 Clinical approach to pulmonary infiltrates in immunosuppressed patient; 3.13 Conclusion; 4 Pulmonary Imaging in Immunocompromised Patients 4.1 Pulmonary infections in immunocompromised patient4.2 Respiratory infections; 4.3 Interventional procedures in patients with pneumonia; 4.4 Summary; 5 Pulmonary Infections in HIV Patients in the Highly Active Antiretroviral Therapy Era; 5.1 Introduction; 5.2 Epidemology and etiology; 5.3 Diagnosis; 5.4 Prognosis; 5.5 Conclusions; 6 Neutropenia; 6.1 Introduction; 6.2 Management of the neutropenic patient; 6.3 Specific infectious diseases; 7 General Management of Suspected Pneumonia in the Solid Organ Transplant Patient; 7.1 Introduction; 7.2 Epidemiology 7.3 Differential diagnosis and non-infectious complications7.4 Diagnostic approach; 7.5 Conclusion; 8 Respiratory Infections Following Haematopoietic Stem Cell Transplantation; 8.1 Immune system recovery after HSCT; 8.2 Bacterial pneumonia; 8.3 Invasive pulmonary aspergillosis; 8.4 Cytomegalovirus; 8.5 Community respiratory viruses; 8.6 Non-infectious pulmonary complications; 8.7 Conclusion; 9 Chronic Non-infectious Pulmonary Complications in Haematopoietic Stem Cell Transplantation; 9.1 Introduction; 9.2 Bronchiolitis Obliterans (BO); 9.3 Bronchiolitis Obliterans organizing pneumonia (BOOP) 9.4 Idiopathic pneumonia syndrome (IPS)9.5 Diffuse alveolar haemorrhage (DAH); 9.6 Peri-engraftment respiratory distress syndrome (PERDS); 9.7 Delayed pulmonary toxicity syndrome (DPTS); 9.8 Pulmonary cytolytic thrombi (PCT); 9.9 Other non-infectious pulmonary complications; 9.10 Summary; 10 Pulmonary Infections in Patients on Chronic Glucocorticoid Treatment; 10.1 Introduction; 10.2 Associated inflammatory response in pneumonia; 10.3 Glucocorticoids: Mechanisms of action; 10.4 Glucocorticoid therapy in clinical practice; 10.5 Diagnostic approach 10.6 Empirical treatment of suspected pneumonia in patients receiving chronic GC therapy |
Record Nr. | UNINA-9910139760703321 |
Chichester, West Sussex, UK ; ; Hoboken, NJ, : John Wiley & Sons, 2009 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Pulmonary infection in the immuno-compromised patient [[electronic resource] ] : strategies for management / / edited by Carlos Agusti ́and Antoni Torres |
Pubbl/distr/stampa | Chichester, West Sussex, UK ; ; Hoboken, NJ, : John Wiley & Sons, 2009 |
Descrizione fisica | 1 online resource (459 p.) |
Disciplina |
616.2/4
616.24 |
Altri autori (Persone) |
AgustíCarlos
Torres MartíA (Antoni) |
Soggetto topico |
Respiratory infections
Lungs - Infections Immunosuppression - Complications |
ISBN |
1-282-23742-X
9786612237423 0-470-71417-4 0-470-71418-2 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
PULMONARY INFECTION IN THE IMMUNOCOMPROMISED PATIENT STRATEGIES FOR MANAGEMENT; Contents; Preface; List of Contributors; 1 Lung Immune Defences in the Immunosuppressed Patient; 1.1 Introduction; 1.2 Host defence function in health; 1.3 Host defence function in select immunocompromised patients; 1.4 Summary and future directions for this field; 2 Microbiological Diagnosis of Respiratory Infections in the Immunocompromised; 2.1 Introduction; 2.2 HIV infection and Mycobacterium tuberculosis; 2.3 HIV infection and non tuberculous mycobacteria (NTM); 2.4 HIV and Pneumocystis jirovecii
2.5 Infections in transplant patients or other immunodeficiencies2.6 Concluding remarks; 3 Diagnosis of Pneumonia in Immunocompromised Patient; 3.1 Introduction; 3.2 Clinical assessment; 3.3 Blood cultures; 3.4 Sputum; 3.5 Endotracheal aspirate; 3.6 Non bronchoscopic bronchoalveolar lavage; 3.7 Protected brush sample (PBS); 3.8 Bronchoalveolar lavage (BAL); 3.9 Transbronchial biopsy (TBB); 3.10 Surgical lung biopsy (SLB); 3.11 Sample processing; 3.12 Clinical approach to pulmonary infiltrates in immunosuppressed patient; 3.13 Conclusion; 4 Pulmonary Imaging in Immunocompromised Patients 4.1 Pulmonary infections in immunocompromised patient4.2 Respiratory infections; 4.3 Interventional procedures in patients with pneumonia; 4.4 Summary; 5 Pulmonary Infections in HIV Patients in the Highly Active Antiretroviral Therapy Era; 5.1 Introduction; 5.2 Epidemology and etiology; 5.3 Diagnosis; 5.4 Prognosis; 5.5 Conclusions; 6 Neutropenia; 6.1 Introduction; 6.2 Management of the neutropenic patient; 6.3 Specific infectious diseases; 7 General Management of Suspected Pneumonia in the Solid Organ Transplant Patient; 7.1 Introduction; 7.2 Epidemiology 7.3 Differential diagnosis and non-infectious complications7.4 Diagnostic approach; 7.5 Conclusion; 8 Respiratory Infections Following Haematopoietic Stem Cell Transplantation; 8.1 Immune system recovery after HSCT; 8.2 Bacterial pneumonia; 8.3 Invasive pulmonary aspergillosis; 8.4 Cytomegalovirus; 8.5 Community respiratory viruses; 8.6 Non-infectious pulmonary complications; 8.7 Conclusion; 9 Chronic Non-infectious Pulmonary Complications in Haematopoietic Stem Cell Transplantation; 9.1 Introduction; 9.2 Bronchiolitis Obliterans (BO); 9.3 Bronchiolitis Obliterans organizing pneumonia (BOOP) 9.4 Idiopathic pneumonia syndrome (IPS)9.5 Diffuse alveolar haemorrhage (DAH); 9.6 Peri-engraftment respiratory distress syndrome (PERDS); 9.7 Delayed pulmonary toxicity syndrome (DPTS); 9.8 Pulmonary cytolytic thrombi (PCT); 9.9 Other non-infectious pulmonary complications; 9.10 Summary; 10 Pulmonary Infections in Patients on Chronic Glucocorticoid Treatment; 10.1 Introduction; 10.2 Associated inflammatory response in pneumonia; 10.3 Glucocorticoids: Mechanisms of action; 10.4 Glucocorticoid therapy in clinical practice; 10.5 Diagnostic approach 10.6 Empirical treatment of suspected pneumonia in patients receiving chronic GC therapy |
Record Nr. | UNINA-9910830864803321 |
Chichester, West Sussex, UK ; ; Hoboken, NJ, : John Wiley & Sons, 2009 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|